Biosensors with left ventricular assist devices.
Mahmoud Abbassy1, Muhammad Zain Ali2, Riya Manas Sharma1
1School of Medicine, RCSI University of Medicine and Health Sciences, Dublin 2, Dublin, Ireland.
Heart Failure Reviews
|June 28, 2024
Summary
Implanted biosensors can monitor heart failure patients with mechanical circulatory support devices (MCSDs), like left ventricular assist devices (LVADs). This continuous monitoring aids early detection of issues, improving patient outcomes.
Area of Science:
- Biomedical Engineering
- Cardiovascular Medicine
- Materials Science
Background:
- Heart failure presents a major global health challenge, contributing significantly to mortality.
- Biochemical and physiological indicators can signal distinct cardiac conditions.
- Mechanical circulatory support devices (MCSDs), including left ventricular assist devices (LVADs), are vital for managing advanced heart failure.
Purpose of the Study:
- To review biosensors suitable for integration with LVADs for monitoring critical biomarkers and physiological parameters.
- To discuss fabrication materials, advantages, and disadvantages of these biosensors.
- To examine the feasibility of using biosensor data for closed-loop control in LVAD systems.
Main Methods:
- Literature review of existing biosensor technologies applicable to MCSDs.
- Analysis of biosensor fabrication materials and their properties.
- Exploration of control system integration strategies using real-time biosensor data.
Main Results:
- Various biosensors show potential for implantation alongside LVADs to track biochemical and physiological changes.
- Different materials offer unique benefits and drawbacks for biosensor construction.
- Integration of biosensors enables continuous monitoring and potential for closed-loop control of LVADs.
Conclusions:
- Implanted biosensors offer a promising avenue for enhanced monitoring of patients with LVADs.
- Early detection of adverse changes through continuous monitoring can improve patient prognosis.
- Future research should focus on overcoming challenges in integrating biosensors for effective closed-loop control systems.
Keywords:
Implantable biosensorLeft ventricular assist device (LVAD)Percutaneous biosensorPressure sensorMore Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


